Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Halda Therapeutics LLC
Headquarters: New Haven, CT, United States of America
Website: https://haldatx.com/
Year Founded: 2018
Status: Private
BioCentury | Aug 30, 2024
Discovery & Translation
Science Spotlight: Roche’s intestinal immuno-organoids, cytokine METRNL’s role in tumors, and more
BioCentury’s roundup of translational innovations
BioCentury | Aug 15, 2024
Finance
Venture Report: Halda bringing RIPTACs into clinic with crossover round
Plus: Abata draws strategic investment from BMS as it preps first human study in multiple sclerosis
BioCentury | Apr 6, 2023
Finance
Canaan’s latest fund smaller than last, reflecting ‘recalibration’ in response to market
$650M thirteenth fund is accompanied by separate $200M vehicle to back existing portfolio companies
BioCentury | Feb 15, 2023
Emerging Company Profile
Halda: making targeted tumor killing harder to resist via RIPTACs
PROTAC pioneer Craig Crews’ latest venture uses induced proximity to sequester proteins no cell can do without, selectively in tumors
Items per page:
1 - 4 of 4